September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Targeted and Immunotherapy Strategies in NSCLC Explored by ESMO
Jun 26, 2025, 09:14

Targeted and Immunotherapy Strategies in NSCLC Explored by ESMO

ESMO – European Society for Medical Oncology shared on LinkedIn:

“Findings from the NeoADAURA and the CheckMate 816 provide novel insights on the role of neoadjuvant osimertinib and nivolumab in the perioperative setting adding to the current knowledge on how to integrate targeted and immunotherapy agents in the treatment planning.

Read the opinion by Marina Chiara Garassino in the ESMO Daily Reporter and learn what key questions remain unanswered.”

More posts featuring NSCLC.